Special Issue "Trends and Prospects in Cardiac MRI"

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Nuclear Medicine & Radiology".

Deadline for manuscript submissions: 18 March 2024 | Viewed by 1331

Special Issue Editor

Department of Advanced Biomedical Sciences, Federico II University, Naples, Italy
Interests: heart failure; non-invasive cardiovascular imaging; preventive cardiology

Special Issue Information

Dear Colleagues,

Over the last 15 years, cardiovascular magnetic resonance (CMR) imaging has progressively evolved to become an indispensable tool in cardiology. It is the gold standard for assessing myocardial function, volumes, and scarring, and has become an indispensable tool in the evaluation of congenital heart disease, heart failure, cardiac masses, pericardial disease, and coronary artery disease. Additionally, CMR imaging is unique in its comprehensive tissue characterization, including the assessment of myocardial edema, myocardial siderosis, myocardial perfusion, and diffuse myocardial fibrosis. Recent innovations in CMR scanner technology and parallel imaging techniques have facilitated the generation of T1 and T2 parametric mapping in order to explore tissue characteristics. In addition, the emergence of strain imaging has enabled cardiologists to evaluate cardiac function beyond conventional metrics and progress in computer processing capabilities, and cloud infrastructure has supported the growth of artificial intelligence in CMR imaging. Accordingly, this Special Issue encourages scientists to present their new findings (from well-established clinical indications to new scenarios), discuss future roles and potential controversies, and identify challenges and questions for future research. We encourage researchers to submit their contributions, either in the form of original research, review articles, or meta-analysis.

Dr. Paola Gargiulo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • cardiac magnetic resonance
  • cardiomyopathies
  • heart failure
  • myocardial fibrosis
  • tissue composition
  • hybrid imaging
  • artificial intelligence

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


19 pages, 1985 KiB  
Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis to Risk Stratification and Therapeutic Management
J. Clin. Med. 2023, 12(10), 3481; https://doi.org/10.3390/jcm12103481 - 16 May 2023
Viewed by 1111
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by the thickening of the heart muscle, which can lead to symptoms such as chest pain, shortness of breath, and an increased risk of sudden cardiac death. However, not all patients with HCM have [...] Read more.
Hypertrophic cardiomyopathy (HCM) is a genetic heart disease characterized by the thickening of the heart muscle, which can lead to symptoms such as chest pain, shortness of breath, and an increased risk of sudden cardiac death. However, not all patients with HCM have the same underlying genetic mutations, and some have conditions that resemble HCM but have different genetic or pathophysiological mechanisms, referred to as phenocopies. Cardiac magnetic resonance (CMR) imaging has emerged as a powerful tool for the non-invasive assessment of HCM and its phenocopies. CMR can accurately quantify the extent and distribution of hypertrophy, assess the presence and severity of myocardial fibrosis, and detect associated abnormalities. In the context of phenocopies, CMR can aid in the differentiation between HCM and other diseases that present with HCM-like features, such as cardiac amyloidosis (CA), Anderson–Fabry disease (AFD), and mitochondrial cardiomyopathies. CMR can provide important diagnostic and prognostic information that can guide clinical decision-making and management strategies. This review aims to describe the available evidence of the role of CMR in the assessment of hypertrophic phenotype and its diagnostic and prognostic implications. Full article
(This article belongs to the Special Issue Trends and Prospects in Cardiac MRI)
Show Figures

Figure 1

Back to TopTop